<DOC>
	<DOCNO>NCT02086058</DOCNO>
	<brief_summary>The aim study ( hypothesis ) identify difference gene expression profile bladder muscle hereby gain great knowledge muscular mechanism cause overactive bladder daytime urinary incontinence child older 5 year . A secondary aim examine gene expression profile differs child neurogenic overactive bladder gene expression profile change childhood till adulthood . Such new knowledge result precisely target hence effective treatment overactive bladder . The result obtain retrieve bladder biopsy child adult suffer overactive bladder neurogenic bladder . These biopsy undergo molecular analysis investigator compare biopises bladder healthy adult child .</brief_summary>
	<brief_title>Gene Expression Overactive Bladder Children</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Diurnal Enuresis</mesh_term>
	<criteria>Group 1 : Group 1 ( nonneurogenic bladder/overactive bladder ) : age 514 year age patient must fill 48hour bladder diary minimum 4 micturition per day ( assess bladder diary ) functional daytime urinary incontinence overactive bladder define urgency sign neurogenic bladder dysfunction invasive urodynamics nonremarkable clinical examination normal BMI ( 397 percentile ) inform oral write consent child parents/legal guardian . In informed consent parent /legal guardian give permission authority ( The Danish Ethical Committee ) , may get information child monitoring quality inspection visit . effect prior treatment least 6 month urotherapy effect prior treatment least 3 month anticholinergic treatment plan undergo cystoscopy anesthesia Group 2 : 514 year age &gt; 18 year old diagnose neurogenic bladder ( i.e . cause myelomeningocele ) inform oral write consent child parents/legal guardian . In informed consent parent /legal guardian give permission authority ( The Danish Ethical Committee ) , may get information child monitoring quality inspection visit . plan undergo cystoscopy anesthesia Group 3 : age 514 year age &gt; 18 year old nonremarkable clinical examination normal void pattern minimum 3 micturition per day plan undergo cystoscopy anesthesia Group 1 : Neurological and/or anatomical abnormality lower urinary tract medical history , clinical biochemical test indicate child suffers type disease ( acute urinary infection diabetes ) condition ( pregnancy ) influence child´s possibility participate study , may effect study parameter examination . ongoing fecal problem fecal incontinence constipation prior surgery involve bladder ongoing urinary tract infection ongoing treatment type medicine may effect study parameter examination Group 2 : medical history , clinical biochemical test indicate child suffers type disease ( diabetes ) condition ( pregnancy ) influence child´s possibility participate study , may affect study parameter examination . ongoing treatment type medicine may affect study parameter examination Group 3 : Neurological and/or anatomical abnormality lower urinary tract urinary incontinence overactive bladder urinary incontinence medical history , clinical biochemical test indicate patient suffers type disease ( acute urinary tract infection diabetes ) condition ( pregnancy ) influence patient´s possibility participate study , may effect study parameter examination . type bladder disease disease secondary affecting bladder prior bladder surgery ongoing urinary tract infection ongoing treatment type medicine may effect study parameter examination .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>overactive bladder</keyword>
	<keyword>daytime urinary incontinence</keyword>
	<keyword>child</keyword>
	<keyword>gene expression</keyword>
</DOC>